17-7014258-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001004333.5(RNASEK):āc.269A>Gā(p.Asn90Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,613,754 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00020 ( 0 hom., cov: 32)
Exomes š: 0.00013 ( 1 hom. )
Consequence
RNASEK
NM_001004333.5 missense
NM_001004333.5 missense
Scores
4
6
8
Clinical Significance
Conservation
PhyloP100: 7.82
Genes affected
RNASEK (HGNC:33911): (ribonuclease K) Enables endoribonuclease activity. Predicted to be involved in RNA phosphodiester bond hydrolysis, endonucleolytic. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
RNASEK-C17orf49 (HGNC:44419): (RNASEK-C17orf49 readthrough) This locus represents naturally occurring read-through transcription between the neighboring RNASEK (ribonuclease, RNase K) and C17orf49 (chromosome 17 open reading frame 49) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is unlikely to produce a protein product. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASEK | NM_001004333.5 | c.269A>G | p.Asn90Ser | missense_variant | 3/3 | ENST00000593646.6 | NP_001004333.3 | |
RNASEK | NR_037715.2 | n.546A>G | non_coding_transcript_exon_variant | 4/4 | ||||
RNASEK | NR_037716.2 | n.325A>G | non_coding_transcript_exon_variant | 3/3 | ||||
RNASEK-C17orf49 | NR_037717.1 | n.532A>G | non_coding_transcript_exon_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASEK | ENST00000593646.6 | c.269A>G | p.Asn90Ser | missense_variant | 3/3 | 1 | NM_001004333.5 | ENSP00000468923.2 | ||
RNASEK-C17orf49 | ENST00000547302.3 | c.122A>G | p.Asn41Ser | missense_variant | 2/7 | 5 | ENSP00000450085.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152136Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152136
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000157 AC: 39AN: 248416Hom.: 1 AF XY: 0.000156 AC XY: 21AN XY: 134886
GnomAD3 exomes
AF:
AC:
39
AN:
248416
Hom.:
AF XY:
AC XY:
21
AN XY:
134886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000131 AC: 191AN: 1461500Hom.: 1 Cov.: 33 AF XY: 0.000139 AC XY: 101AN XY: 727020
GnomAD4 exome
AF:
AC:
191
AN:
1461500
Hom.:
Cov.:
33
AF XY:
AC XY:
101
AN XY:
727020
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74442
GnomAD4 genome
AF:
AC:
31
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
20
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.386A>G (p.N129S) alteration is located in exon 3 (coding exon 3) of the RNASEK gene. This alteration results from a A to G substitution at nucleotide position 386, causing the asparagine (N) at amino acid position 129 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;.
PROVEAN
Pathogenic
D;.;.;.;.
REVEL
Uncertain
Sift
Benign
D;.;.;.;.
Sift4G
Uncertain
D;T;D;D;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -1
DS_DL_spliceai
Position offset: 19
Find out detailed SpliceAI scores and Pangolin per-transcript scores at